Allulose
Allulose, also called D-psicose, is a rare monosaccharide found naturally in small amounts in foods such as figs and raisins and produced commercially from fructose. It has roughly 70% of the sweetness of sucrose but contributes very little metabolizable energy because most absorbed allulose is not used as a conventional fuel and is excreted largely unchanged.
Glycemic response. Unlike sucrose or glucose, allulose produces little direct rise in blood glucose or insulin. When consumed with a carbohydrate-containing meal, several small human studies have reported lower postprandial glucose excursions. Proposed explanations include effects on hepatic glucose handling, intestinal carbohydrate absorption and incretin signaling, although the exact contribution of each mechanism remains under study.
Energy metabolism. Experimental models suggest that allulose can influence pathways related to fat oxidation, lipogenesis and energy sensing, including AMPK-associated signaling. In rodents fed energy-dense diets, allulose has reduced weight gain, visceral fat accumulation and liver fat in several experiments. These animal results are more dramatic than the effects documented so far in humans.
Body weight and lipids. Human trials are smaller and shorter. Some have reported modest reductions in body fat, waist-related measures or triglycerides when allulose replaces caloric sugars. The key distinction is replacement: substituting allulose for sugar reduces available energy and glycemic load, whereas adding it without reducing other calories offers much less reason to expect weight benefit.
Glycation and aging biology. Lower postprandial glucose exposure could theoretically reduce formation of advanced glycation end products over time. Allulose has also shown antioxidant and anti-inflammatory effects in cell and animal models. These mechanisms are relevant to aging research, but no human trial has demonstrated that allulose slows biological aging or extends lifespan.
Liver and metabolic health. Rodent studies frequently report reductions in hepatic fat and expression of lipogenic enzymes together with greater fatty-acid oxidation. Early human evidence is consistent with a possible metabolic benefit, but it is not strong enough to treat allulose as a therapy for fatty liver disease.
Dental and food applications. Because allulose provides bulk and browning properties closer to sugar than many high-intensity sweeteners, it can be useful in baked goods, frozen desserts and beverages. It does not behave identically to sucrose in every formulation and can brown readily during heating.
Gastrointestinal tolerance. The main practical limitation is digestive tolerance. Larger single doses can cause bloating, abdominal discomfort or diarrhea, particularly when intake rises rapidly. Tolerance depends on dose, body size and whether allulose is consumed with other poorly absorbed carbohydrates or polyols.
Safety. Available human and toxicology data support a generally favorable safety profile at commonly used food amounts. Long-term evidence is less extensive than for traditional sugars, and very high intakes are unnecessary given the gastrointestinal dose limit.
Overall, allulose is best understood as a low-energy sugar substitute with favorable effects on postprandial glycemia and promising metabolic data. Its strongest practical value comes from replacing caloric sugars. Claims that it directly prevents aging, activates longevity pathways in a clinically important way or extends human lifespan remain unproven.